P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state

Epithelial-mesenchymal transition (also known as EMT) is a fundamental mechanism occurring during embryonic development and tissue differentiation, being also crucial for cancer progression. Actually, the EMT program contributes to the dissemination of cancer cells from solid tumors and to the forma...

Full description

Bibliographic Details
Main Authors: Ana Sofia Ribeiro, Joana eParedes
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00371/full
_version_ 1811263656730558464
author Ana Sofia Ribeiro
Joana eParedes
author_facet Ana Sofia Ribeiro
Joana eParedes
author_sort Ana Sofia Ribeiro
collection DOAJ
description Epithelial-mesenchymal transition (also known as EMT) is a fundamental mechanism occurring during embryonic development and tissue differentiation, being also crucial for cancer progression. Actually, the EMT program contributes to the dissemination of cancer cells from solid tumors and to the formation of micro-metastasis that subsequently develop into clinically detectable metastases. Besides being a process that is defined by the progressive loss of epithelial cell characteristics and the acquisition of mesenchymal features, EMT has also been implicated in therapy resistance, immune escape and maintenance of cancer stem cell properties, such as self-renewal capacity.However, the majority of the studies usually neglect the progressive alterations occurring during intermediate EMT states, which imply a range of phenotypic cellular heterogeneity that can potentially generate more metastable and plastic tumor cells. In fact, few studies have tried to identify these transitory states, partly due to the current lack of a detailed understanding of EMT, as well as of reliable readouts for its progression. Herein, a brief review of evidences is presented, showing that P-cadherin expression, which has been already identified as a breast cancer stem cell marker and invasive promoter, is probably able to identify an intermediate EMT state associated with a metastable phenotype. This hypothesis is based on our own work, as well as on the results described by others, which suggest the use of P-cadherin as a promising EMT marker, clearly functioning as an important clinical prognostic factor and putative therapeutic target in breast carcinogenesis.
first_indexed 2024-04-12T19:49:16Z
format Article
id doaj.art-f338107c0779480080bd1674cb9af5fb
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T19:49:16Z
publishDate 2015-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-f338107c0779480080bd1674cb9af5fb2022-12-22T03:18:53ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2015-01-01410.3389/fonc.2014.00371123587P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT stateAna Sofia Ribeiro0Joana eParedes1IPATIMUPIPATIMUPEpithelial-mesenchymal transition (also known as EMT) is a fundamental mechanism occurring during embryonic development and tissue differentiation, being also crucial for cancer progression. Actually, the EMT program contributes to the dissemination of cancer cells from solid tumors and to the formation of micro-metastasis that subsequently develop into clinically detectable metastases. Besides being a process that is defined by the progressive loss of epithelial cell characteristics and the acquisition of mesenchymal features, EMT has also been implicated in therapy resistance, immune escape and maintenance of cancer stem cell properties, such as self-renewal capacity.However, the majority of the studies usually neglect the progressive alterations occurring during intermediate EMT states, which imply a range of phenotypic cellular heterogeneity that can potentially generate more metastable and plastic tumor cells. In fact, few studies have tried to identify these transitory states, partly due to the current lack of a detailed understanding of EMT, as well as of reliable readouts for its progression. Herein, a brief review of evidences is presented, showing that P-cadherin expression, which has been already identified as a breast cancer stem cell marker and invasive promoter, is probably able to identify an intermediate EMT state associated with a metastable phenotype. This hypothesis is based on our own work, as well as on the results described by others, which suggest the use of P-cadherin as a promising EMT marker, clearly functioning as an important clinical prognostic factor and putative therapeutic target in breast carcinogenesis.http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00371/fullbreast cancermetastasisEMT transitionP-cadherinmetastable phenotype
spellingShingle Ana Sofia Ribeiro
Joana eParedes
P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state
Frontiers in Oncology
breast cancer
metastasis
EMT transition
P-cadherin
metastable phenotype
title P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state
title_full P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state
title_fullStr P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state
title_full_unstemmed P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state
title_short P-cadherin linking breast cancer stem cells and invasion: a promising marker to identify an intermediate/metastable EMT state
title_sort p cadherin linking breast cancer stem cells and invasion a promising marker to identify an intermediate metastable emt state
topic breast cancer
metastasis
EMT transition
P-cadherin
metastable phenotype
url http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00371/full
work_keys_str_mv AT anasofiaribeiro pcadherinlinkingbreastcancerstemcellsandinvasionapromisingmarkertoidentifyanintermediatemetastableemtstate
AT joanaeparedes pcadherinlinkingbreastcancerstemcellsandinvasionapromisingmarkertoidentifyanintermediatemetastableemtstate